Full View

Safety of potential breast milk exposure to IFN-β or glatiramer acetate: one-year infant outcomes

AI Ciplea, A Langer-Gould, A Stahl, S Thiel… - Neurology …, 2020 - AAN Enterprises
Objective To determine whether potential breast milk exposure to interferon-beta (IFN-β) or
glatiramer acetate (GA) is safe for the infant. Methods We identified 74 infants born to 69 …
被引用次数：42 相关文章
[HTML] nih.gov

[HTML][HTML] Safety of potential breast milk exposure to IFN-β or glatiramer acetate: One-year infant outcomes

AI Ciplea, A Langer-Gould, A Stahl, S Thiel… - Neurology® …, 2020 - ncbi.nlm.nih.gov
Objective To determine whether potential breast milk exposure to interferon-beta (IFN-β) or
glatiramer acetate (GA) is safe for the infant. Methods We identified 74 infants born to 69 …

Safety of potential breast milk exposure to IFN-β or glatiramer acetate: One-year infant outcomes.

AI Ciplea, A Langer-Gould, A Stahl, S Thiel… - Neurology (r) …, 2020 - europepmc.org
Objective To determine whether potential breast milk exposure to interferon-beta (IFN-β) or
glatiramer acetate (GA) is safe for the infant. Methods We identified 74 infants born to 69 …

Safety of potential breast milk exposure to IFN-β or glatiramer acetate: One-year infant outcomes

AI Ciplea, A Langer-Gould, A Stahl… - Neurology (R) …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective To determine whether potential breast milk exposure to interferon-beta (IFN-β) or
glatiramer acetate (GA) is safe for the infant. Methods We identified 74 infants born to 69 …